| Protein misfolding, functional amyloid, and human disease F Chiti, CM Dobson Annu. Rev. Biochem. 75 (1), 333-366, 2006 | 7625 | 2006 |
| Protein folding and misfolding CM Dobson Nature 426 (6968), 884-890, 2003 | 5923 | 2003 |
| Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases M Bucciantini, E Giannoni, F Chiti, F Baroni, L Formigli, J Zurdo, N Taddei, ... nature 416 (6880), 507-511, 2002 | 3051 | 2002 |
| Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade F Chiti, CM Dobson Annual review of biochemistry 86 (1), 27-68, 2017 | 2561 | 2017 |
| The amyloid state and its association with protein misfolding diseases TPJ Knowles, M Vendruscolo, CM Dobson Nature reviews Molecular cell biology 15 (6), 384-396, 2014 | 2537 | 2014 |
| Protein misfolding, evolution and disease CM Dobson Trends in biochemical sciences 24 (9), 329-332, 1999 | 2505 | 1999 |
| Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution M Stefani, CM Dobson Journal of molecular medicine 81, 678-699, 2003 | 2100 | 2003 |
| Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism SIA Cohen, S Linse, LM Luheshi, E Hellstrand, DA White, L Rajah, ... Proceedings of the National Academy of Sciences 110 (24), 9758-9763, 2013 | 1509 | 2013 |
| Designing conditions for in vitro formation of amyloid protofilaments and fibrils F Chiti, P Webster, N Taddei, A Clark, M Stefani, G Ramponi, CM Dobson Proceedings of the National Academy of Sciences 96 (7), 3590-3594, 1999 | 1389 | 1999 |
| Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis DR Booth, M Sunde, V Bellotti, CV Robinson, WL Hutchinson, PE Fraser, ... Nature 385 (6619), 787-793, 1997 | 1332 | 1997 |
| Rationalization of the effects of mutations on peptide andprotein aggregation rates F Chiti, M Stefani, N Taddei, G Ramponi, CM Dobson Nature 424 (6950), 805-808, 2003 | 1301 | 2003 |
| Chemical space and biology. CM Dobson Nature 432 (7019), 2004 | 1267 | 2004 |
| An analytical solution to the kinetics of breakable filament assembly TPJ Knowles, CA Waudby, GL Devlin, SIA Cohen, A Aguzzi, ... Science 326 (5959), 1533-1537, 2009 | 1241 | 2009 |
| Principles of protein folding, misfolding and aggregation CM Dobson Seminars in cell & developmental biology 15 (1), 3-16, 2004 | 1222 | 2004 |
| The structural basis of protein folding and its links with human disease CM Dobson Philosophical Transactions of the Royal Society of London. Series B …, 2001 | 1210 | 2001 |
| Protein folding: a perspective from theory and experiment CM Dobson, A Šali, M Karplus Angewandte Chemie International Edition 37 (7), 868-893, 1998 | 1172 | 1998 |
| Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques DK Wilkins, SB Grimshaw, V Receveur, CM Dobson, JA Jones, LJ Smith Biochemistry 38 (50), 16424-16431, 1999 | 1137 | 1999 |
| The protofilament structure of insulin amyloid fibrils JL Jiménez, EJ Nettleton, M Bouchard, CV Robinson, CM Dobson, ... Proceedings of the National Academy of Sciences 99 (14), 9196-9201, 2002 | 1007 | 2002 |
| Amyloid fibrils from muscle myoglobin M Fändrich, MA Fletcher, CM Dobson Nature 410 (6825), 165-166, 2001 | 1004 | 2001 |
| Direct observation of the interconversion of normal and toxic forms of α-synuclein N Cremades, SIA Cohen, E Deas, AY Abramov, AY Chen, A Orte, ... Cell 149 (5), 1048-1059, 2012 | 1001 | 2012 |
